Risk factors and outcomes of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia in the neonate: A case-case-control study

Journal of Infection and Chemotherapy

Volumn 22, Issue 7, 2016, Pages 444-449

  Thatrimontrichai, Anucha ^a   Techato, Chirabat ^a,b   Dissaneevate, Supaporn ^a   Janjindamai, Waricha ^a   Maneenil, Gunlawadee ^a   Kritsaneepaiboon, Supika ^a   Tanaanantarak, Pattama ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b Songkhla Hospital   (Thailand)

Author keywords

Acinetobacter baumannii; Carbapenem; Colonization pressure; Drug resistance; Newborn; Pneumonia

Indexed keywords

AMIKACIN; AMPICILLIN; CARBAPENEM; CEFAZOLIN; CEFOPERAZONE PLUS SULBACTAM; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN; CLOXACILLIN; COLISTIN; GENTAMICIN; IMIPENEM; LUNG SURFACTANT; MEROPENEM; POLYMYXIN; VANCOMYCIN; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL STRAIN; BIRTH WEIGHT; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII; CARBAPENEM SUSCEPTIBLE ACINETOBACTER BAUMANNII; CASE CONTROL STUDY; CESAREAN SECTION; CONTROLLED STUDY; DISK DIFFUSION; EXTREMELY LOW BIRTH WEIGHT; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MECHANICAL VENTILATOR; MORTALITY RATE; MULTIVARIATE ANALYSIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NEWBORN INTENSIVE CARE; PREMATURITY; RISK FACTOR; SEPTIC SHOCK; UMBILICAL ARTERY CATHETERIZATION; VENTILATOR ASSOCIATED PNEUMONIA; ACINETOBACTER INFECTIONS; DRUG EFFECTS; MICROBIOLOGY; PNEUMONIA, VENTILATOR-ASSOCIATED; TREATMENT OUTCOME;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; CARBAPENEMS; CASE-CONTROL STUDIES; CEPHALOSPORINS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PNEUMONIA, VENTILATOR-ASSOCIATED; PULMONARY SURFACTANTS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84971655996     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2016.03.013     Document Type: Article

References (36)

1. Tekin R., Dal T., Pirinccioglu H., Oygucu S.E. A 4-year surveillance of device-associated nosocomial infections in a neonatal intensive care unit. Pediatr Neonatol 2013, 54:303-308.
2. Tan B., Zhang F., Zhang X., Huang Y.L., Gao Y.S., Liu X., et al. Risk factors for ventilator-associated pneumonia in the neonatal intensive care unit: a meta-analysis of observational studies. Eur J Pediatr 2014, 173:427-434.
3. Apisarnthanarak A., Holzmann-Pazgal G., Hamvas A., Olsen M.A., Fraser V.J. Ventilator-associated pneumonia in extremely preterm neonates in a neonatal intensive care unit: characteristics, risk factors, and outcomes. Pediatrics 2003, 112:1283-1289.
4. Deng C., Li X., Zou Y., Wang J., Wang J., Namba F., et al. Risk factors and pathogen profile of ventilator-associated pneumonia in a neonatal intensive care unit in China. Pediatr Int 2011, 53:332-337.
5. Tripathi S.H., Malik G.K., Jain A., Kohli N. Study of ventilator associated pneumonia in neonatal intensive care unit: characteristics, risk factors and outcome. Internet J Med Update 2010, 5:12-19.
6. Chang H.C., Chen Y.C., Lin M.C., Liu S.F., Chung Y.H., Su M.C., et al. Mortality risk factors in patients with Acinetobacter baumannii ventilator-associated pneumonia. J Formos Med Assoc 2011, 110:564-571.
7. Garnacho-Montero J., Ortiz-Leyba C., Fernandez-Hinojosa E., Aldabo-Pallas T., Cayuela A., Marquez-Vacaro J.A., et al. Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intensive Care Med 2005, 31:649-655.
8. Aydemir H., Akduman D., Piskin N., Comert F., Horuz E., Terzi A., et al. Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia. Epidemiol Infect 2013, 141:1214-1222.
9. Werarak P., Waiwarawut J., Tharavichitkul P., Pothirat C., Rungruanghiranya S., Geater S.L., et al. Acinetobacter baumannii nosocomial pneumonia in tertiary care hospitals in Thailand. J Med Assoc Thai 2012, 95(Suppl. 2):S23-S33.
10. Thatrimontrichai A., Rujeerapaiboon N., Janjindamai W., Dissaneevate S., Maneenil G., Kritsaneepaiboon S., et al. Outcomes and risk factors of ventilator-associated pneumonia in neonates. World J Pediatr 2016, [in press].
11. Vattanavanit V., Chayakul P. Acinetobacter infections in the intensive care unit. Songkla Med J 2013, 31:91-100.
12. Thatrimontrichai A., Apisarnthanarak A., Chanvitan P., Janjindamai W., Dissaneevate S., Maneenil G. Risk factors and outcomes of carbapenem-resistant Acinetobacter baumannii bacteremia in neonatal intensive care unit: a case-case-control study. Pediatr Infect Dis J 2013, 32:140-145.
13. Thatrimontrichai A., Chanvitan P., Janjindamai W., Dissaneevate S., Jefferies A., Shah V. Trends in neonatal sepsis in a neonatal intensive care unit in Thailand before and after construction of a new facility. Asian Biomed 2014, 8:771-778.
14. The Association for Professionals in Infection Control and Epidemiology, The Centers for Disease Control and Prevention, The Institute for Healthcare Improvement, The National Foundation for Infectious Diseases, The Society for Healthcare Epidemiology of America, The World Health Organization World Alliance for Patient Safety Measuring hand hygiene adherence: overcoming the challenges 2009, 29-32.
15. The Centers for Disease Control and Prevention (CDC) and National Healthcare Safety Network (NHSN) CDC/NHSN surveillance definitions for specific types of infections 2014.
16. Goldstein B., Giroir B., Randolph A. International consensus conference on Pediatric S. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005, 6:2-8.
17. CLSI Performance standards for antimicrobial susceptibility testing 2014, Twenty-Fourth Informational Supplement. CLSI document M100-S24, Clinical and Laboratory Standards Institute, Wayne, PA.
18. Malamitsi-Puchner A., Protonotariou E., Boutsikou T., Makrakis E., Sarandakou A., Creatsas G. The influence of the mode of delivery on circulating cytokine concentrations in the perinatal period. Early Hum Dev 2005, 81:387-392.
19. Schulpis K.H., Vlachos G.D., Karikas G.A., Papakonstantinou E.D., Vlachos D.G., Papassotiriou I., et al. The effect of the mode of delivery on maternal-neonatal interleukin-6, biogenic amine and their precursor amino acid concentrations. Clin Chem Lab Med 2008, 46:1624-1630.
20. Protonotariou E., Chrelias C., Kassanos D., Kapsambeli H., Trakakis E., Sarandakou A. Immune response parameters during labor and early neonatal life. In Vivo 2010, 24:117-123.
21. Morrison J.J., Rennie J.M., Milton P.J. Neonatal respiratory morbidity and mode of delivery at term: influence of timing of elective caesarean section. Br J Obstet Gynaecol 1995, 102:101-106.
22. Zanardo V., Simbi A.K., Franzoi M., Solda G., Salvadori A., Trevisanuto D. Neonatal respiratory morbidity risk and mode of delivery at term: influence of timing of elective caesarean delivery. Acta Paediatr 2004, 93:643-647.
23. Moore H.C., de Klerk N., Holt P., Richmond P.C., Lehmann D. Hospitalisation for bronchiolitis in infants is more common after elective caesarean delivery. Arch Dis Child 2012, 97:410-414.
24. Routsi C., Pratikaki M., Platsouka E., Sotiropoulou C., Nanas S., Markaki V., et al. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes. Infection 2010, 38:173-180.
25. Zheng Y.L., Wan Y.F., Zhou L.Y., Ye M.L., Liu S., Xu C.Q., et al. Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia. Am J Infect Control 2013, 41:e59-63.
26. Polin R.A., Carlo W.A. Committee on Fetus and Newborn, American Academy of Pediatrics. Surfactant replacement therapy for preterm and term neonates with respiratory distress. Pediatrics 2014, 133:156-163.
27. Thamlikitkul V., Santiprasitkul S., Suntanondra L., Pakaworawuth S., Tiangrim S., Udompunthurak S., et al. Skin flora of patients in Thailand. Am J Infect Control 2003, 31:80-84.
28. Cernada M., Aguar M., Brugada M., Gutierrez A., Lopez J.L., Castell M., et al. Ventilator-associated pneumonia in newborn infants diagnosed with an invasive bronchoalveolar lavage technique: a prospective observational study. Pediatr Crit Care Med 2013, 14:55-61.
29. Afjeh S.A., Sabzehei M.K., Karimi A., Shiva F., Shamshiri A.R. Surveillance of ventilator-associated pneumonia in a neonatal intensive care unit: characteristics, risk factors, and outcome. Arch Iran Med 2012, 15:567-571.
30. Petdachai W. Ventilator-associated pneumonia in a newborn intensive care unit. Southeast Asian J Trop Med Public Health 2004, 35:724-729.
31. Ozgur E.S., Horasan E.S., Karaca K., Ersoz G., Nayci Atis S., Kaya A. Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii: risk factors, clinical features, and outcomes. Am J Infect Control 2014, 42:206-208.
32. Morgan D.J., Liang S.Y., Smith C.L., Johnson J.K., Harris A.D., Furuno J.P., et al. Frequent multidrug-resistant Acinetobacter baumannii contamination of gloves, gowns, and hands of healthcare workers. Infect Control Hosp Epidemiol 2010, 31:716-721.
33. Rosa R., Arheart K.L., Depascale D., Cleary T., Kett D.H., Namias N., et al. Environmental exposure to carbapenem-resistant Acinetobacter baumannii as a risk factor for patient acquisition of A. baumannii. Infect Control Hosp Epidemiol 2014, 35:430-433.
34. Phumisantiphong U., Diraphat P., Utrarachkij F., Uaratanawong S., Siripanichgon K. Clonal spread of carbapenem resistant Acinetobacter baumannii in the patients and their environment at BMA Medical College and Vajira Hospital. J Med Assoc Thai 2009, 92(Suppl. 7):S173-S180.
35. Koksal N., Hacimustafaoglul M., Celebi S., Ozakin C. Nonbronchoscopic bronchoalveolar lavage for diagnosing ventilator-associated pneumonia in newborns. Turk J Pediatr 2006, 48:213-220.
36. Chusri S., Silpapojakul K., McNeil E., Singkhamanan K., Chongsuvivatwong V. Impact of antibiotic exposure on occurrence of nosocomial carbapenem-resistant Acinetobacter baumannii infection: a case control study. J Infect Chemother 2015, 21:90-95.